Published in Europace on May 17, 2017
Major bleeding in patients with atrial fibrillation receiving apixaban or warfarin: The ARISTOTLE Trial (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation): Predictors, Characteristics, and Clinical Outcomes. J Am Coll Cardiol (2014) 2.18
Apixaban 5 mg Twice Daily and Clinical Outcomes in Patients With Atrial Fibrillation and Advanced Age, Low Body Weight, or High Creatinine: A Secondary Analysis of a Randomized Clinical Trial. JAMA Cardiol (2016) 1.43
Usefulness of QRS voltage correction by body mass index to improve electrocardiographic detection of left ventricular hypertrophy in patients with systemic hypertension. Am J Cardiol (2014) 1.37
Clinical research and trials in developing countries. Stat Med (2002) 0.93
Use of ambulatory blood pressure measurement in the definition of resistant hypertension: a review of the evidence. Hypertens Res (2014) 0.87
Current presentation and management of 7148 patients with atrial fibrillation in cardiology and internal medicine hospital centers: the ATA AF study. Int J Cardiol (2012) 0.83
Risk of stroke in chronic heart failure patients with preserved ejection fraction, but without atrial fibrillation: analysis of the CHARM-Preserved and I-Preserve trials. Eur Heart J (2017) 0.83
Temporal trends in the epidemiology, management, and outcome of patients with cardiogenic shock complicating acute coronary syndromes. Eur J Heart Fail (2015) 0.81
Rationale and design of the Chinese Atrial Fibrillation Registry Study. BMC Cardiovasc Disord (2016) 0.81
Timing of breakfast does not influence therapeutic efficacy of liquid levothyroxine formulation. Endocrine (2015) 0.81
Clinical outcomes of patients with diabetes and atrial fibrillation treated with apixaban: results from the ARISTOTLE trial. Eur Heart J Cardiovasc Pharmacother (2015) 0.80
Efficacy of Statin Therapy in Pulmonary Arterial Hypertension: A Systematic Review and Meta-Analysis. Sci Rep (2016) 0.80
Hospital readmissions of patients with heart failure: the impact of hospital and primary care organizational factors in Northern Italy. PLoS One (2015) 0.79
Contemporary Trends and Age-Specific Sex Differences in Management and Outcome for Patients With ST-Segment Elevation Myocardial Infarction. J Am Heart Assoc (2016) 0.79
Combining therapeutic hypothermia and emergent coronary angiography in out-of-hospital cardiac arrest survivors: Optimal post-arrest care for the best patient. Eur Heart J Acute Cardiovasc Care (2014) 0.78
Comparison of dabigatran versus warfarin in diabetic patients with atrial fibrillation: Results from the RE-LY trial. Int J Cardiol (2015) 0.77
Non-major bleeding with apixaban versus warfarin in patients with atrial fibrillation. Heart (2016) 0.76
Heart failure in low- and middle-income countries: background, rationale, and design of the INTERnational Congestive Heart Failure Study (INTER-CHF). Am Heart J (2015) 0.76
Genome-Wide Association Study Identifies That the ABO Blood Group System Influences Interleukin-10 Levels and the Risk of Clinical Events in Patients with Acute Coronary Syndrome. PLoS One (2015) 0.76
Prognostic usefulness of left ventricular hypertrophy by electrocardiography in patients with atrial fibrillation (from the Randomized Evaluation of Long-Term Anticoagulant Therapy Study). Am J Cardiol (2013) 0.76
Economic Analysis of Apixaban Therapy for Patients With Atrial Fibrillation From a US Perspective: Results From the ARISTOTLE Randomized Clinical Trial. JAMA Cardiol (2017) 0.76
Intensive insulin-glucose infusion regimens with long-term or standard glucose control did not differ for reducing mortality in type 2 diabetes mellitus and MI. ACP J Club (2005) 0.75
Premature Cardiac Aging in South Asian Compared to Afro-Caribbean Subjects in a Community-Based Screening Study. J Am Heart Assoc (2016) 0.75
Edoxaban in the evolving scenario of non vitamin K antagonist oral anticoagulants imputed placebo analysis and multiple treatment comparisons. PLoS One (2014) 0.75
Risk and decision making in patients with hypertension. Lancet (2014) 0.75
Masked and White-Coat Hypertension: Moving to African Americans. J Am Coll Cardiol (2015) 0.75
Endotoxemia as a trigger of thrombosis in cirrhosis. Haematologica (2016) 0.75
Efficacy and Safety of Apixaban Versus Warfarin in Patients with Atrial Fibrillation and a History of Cancer: Insights From the ARISTOTLE Trial. Am J Med (2017) 0.75
Effects of tibolone on fibrinogen and antithrombin III: A systematic review and meta-analysis of controlled trials. Pharmacol Res (2017) 0.75
Vitamin K and non-vitamin K antagonist oral anticoagulants for non-valvular atrial fibrillation in real-life. Eur J Intern Med (2016) 0.75
Efficacy of non-vitamin-K antagonist oral anticoagulants for intracardiac thrombi resolution in nonvalvular atrial fibrillation. Drug Discov Today (2017) 0.75
Antithrombotic prophylaxis of atrial fibrillation in an Italian real-world setting: a retrospective study. Vasc Health Risk Manag (2017) 0.75
The SPRINT trial. J Am Soc Hypertens (2015) 0.75
Effect of Apixaban on All-Cause Death in Patients with Atrial Fibrillation: a Meta-Analysis Based on Imputed Placebo Effect. Cardiovasc Drugs Ther (2017) 0.75
Clinical Outcomes and History of Fall in Patients with Atrial Fibrillation Treated with Oral Anticoagulation: Insights From the ARISTOTLE Trial. Am J Med (2017) 0.75
Embolic Stroke of Undetermined Source and Detection of Atrial Fibrillation on Follow-Up: How Much Causality Is There? J Stroke Cerebrovasc Dis (2016) 0.75
Efficacy and Safety of Apixaban Compared With Warfarin in Patients With Atrial Fibrillation and Peripheral Artery Disease: Insights From the ARISTOTLE Trial. J Am Heart Assoc (2017) 0.75
Efficacy and Safety of Alternate-Day Versus Daily Dosing of Statins: a Systematic Review and Meta-Analysis. Cardiovasc Drugs Ther (2017) 0.75
Characterising and predicting bleeding in high-risk patients with an acute coronary syndrome. Heart (2015) 0.75
Anticoagulation therapy and clinical outcomes in patients with recently diagnosed atrial fibrillation: Insights from the ARISTOTLE trial. Int J Cardiol (2016) 0.75
Short-term dabigatran interruption before cardiac rhythm device implantation: multi-centre experience from the RE-LY trial. Europace (2017) 0.75
Recent trends in management and outcome of patients with acute coronary syndromes and atrial fibrillation. Int J Cardiol (2017) 0.75
Permanent discontinuation of non vitamin K oral anticoagulants in real life patients with non-valvular atrial fibrillation. Int J Cardiol (2017) 0.75
Management of hypertension in the very old: an intensive reduction of blood pressure should be achieved in most patients. J Hum Hypertens (2020) 0.75
Progression of paroxysmal to persistent atrial fibrillation: Canadian Registry of Atrial Fibrillation 10-year follow-up. Heart Rhythm (2017) 0.75
Influence of renal function on anticoagulation control in patients with non-valvular atrial fibrillation taking vitamin K antagonists. Int J Clin Pract (2017) 0.75